‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
<iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/29060588/height/90/theme/custom/thumbnail/no/direction/backward/render-playlist/no/custom-color/123c60/" height="90" width="100%" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe>
Speaking of SurgOnc
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
30
00:00:00
/ 00:15:33
30
